![]() |
市場調查報告書
商品編碼
1662605
2030 年奈米乳劑市場預測:按類型、成分、製備方法、穩定性、給藥途徑、應用和地區進行的全球分析Nanoemulsion Market Forecasts to 2030 - Global Analysis By Type (Oil-in-Water Nanoemulsion, Water-in-Oil Nanoemulsion and Bi-Continuous Nanoemulsion), Composition, Preparation Method, Stability, Route of Administration, Application and By Geography |
根據 Stratistics MRC 的數據,全球奈米乳液市場預計在 2024 年達到 128.4 億美元,到 2030 年將達到 201.7 億美元,預測期內的複合年成長率為 9.2%。
乳化是一種由細分散液滴組成的乳化系統,液滴尺寸通常在 20 至 200 奈米之間。這些系統是透明或半透明的並且動態穩定。描述了一種用於配製能夠同時攜帶親水性和親油性化合物並且與傳統乳化相比具有更佳性能和穩定性的產品的多功能解決方案。
根據 News-Medical.Net 2020 年 9 月的一篇研究報導,研究人員表示,奈米乳劑系統可以誘發與減毒活病毒疫苗類似的免疫反應,但沒有復發的風險。
護膚和抗衰老產品需求增加
乳化增強維生素、抗氧化劑和胜肽等活性成分的滲透和吸收。這些成分可以深入皮膚,提高產品的功效並增強其抗衰老功效。此外,乳化還具有更高的穩定性、更長的保存期限以及製造更輕、不油膩配方的能力,所有這些都吸引了尋求更有效和創新的護膚解決方案的消費者。這種需求推動了奈米乳液技術在化妝品行業的應用。
穩定性問題
乳化的穩定性問題是由於顆粒聚集、相分離和聚結等因素引起的,這些因素可能隨著時間的推移和在某些儲存條件下發生。這些問題通常是由配方不當、高能量需求或溫度波動或 pH 值變化等外部因素引起的。這種不穩定性限制了奈米乳液產品的保存期限和功效,尤其是在藥品和化妝品中,從而阻礙了市場的成長。
藥品需求不斷成長
乳化是有效傳遞活性藥物成分的理想選擇,因為它們可以提高水溶性差的藥物的生物有效性、穩定性和溶解度。特別是隨著標靶治療、疫苗和生技藥品等新型製劑的持續研究,乳化代表了改善藥物吸收和控制釋放的一種有希望的解決方案。慢性病的增加、個人化醫療以及對更安全、更有效的藥物傳遞系統的需求進一步推動了奈米乳劑技術在製藥領域的應用,從而推動了市場的成長。
製造成本高
乳化的生產成本很高,因為它們需要專門的設備、先進的原料和複雜的製造過程來精確控制液滴的大小和穩定性。高壓均質化和微流體化等技術導致成本上升。此外,確保一致性、可擴展性和法規遵循會帶來越來越大的經濟負擔。這種成本上升可能會限制市場可近性,從而阻礙市場成長,尤其是對於中小型企業而言。
COVID-19 的影響
COVID-19 疫情以多種方式影響了奈米乳液市場。從積極的一面來看,疫苗輸送系統、抗病毒藥物和個人防護產品等藥物應用對奈米乳液的需求增加。消毒劑、消毒劑和護膚品的需求激增也促進了市場的發展。然而,供應鏈中斷、製造延遲以及研發活動低迷阻礙了成長。儘管存在這些挑戰,但由於對先進藥物輸送系統的需求不斷成長,市場表現出了韌性。
預計油包水奈米乳液市場在預測期內將佔據最大佔有率
預計在整個預測期內,油包水奈米乳液將佔據最大的市場佔有率。油包水乳化乳化一種將微小的油滴分散在水相中的乳液,油滴尺寸通常在 20 至 200 奈米範圍內。這種乳化廣泛應用於藥品、化妝品和食品。油包水乳化具有更高的穩定性、更低的毒性和控制釋放,使其成為藥物傳輸系統、護膚產品和機能性食品配方的理想選擇。
預計預測期內食品和飲料產業將以最高的複合年成長率成長。
預計預測期內食品和飲料產業將以最高的複合年成長率成長。在食品和飲料工業中,乳化用於改善風味、營養成分和生物活性化合物的傳輸。乳化可有效用於強化飲料、機能性食品和調味品等產品,因為它們可以提高維生素、抗氧化劑和精油等成分的穩定性、溶解度和吸收率。提供始終如一的品質並維持乳液不分離的能力正在推動該領域的創新。
由於對先進藥物輸送系統、個人保健產品以及食品和飲料應用的需求不斷增加,預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家是主要貢獻者,這得益於其製藥、化妝品和營養保健品產業的擴張。該地區不斷提高的醫療意識以及對生物技術和奈米技術的投資不斷增加,正在支持市場擴張。此外,化妝品和食品領域對環保和永續產品的需求正在刺激該地區採用乳化。
由於藥物輸送系統、製藥和化妝品行業的進步,預計北美在預測期內將實現最高的複合年成長率。由於對創新藥物製劑(包括疫苗和生技藥品)的需求不斷成長,美國是該市場的主要參與企業。該地區受益於強勁的研發活動、技術進步和完善的醫療保健基礎設施。此外,消費者對化妝品和食品領域的環保和永續配方的需求不斷增加,進一步推動了北美對奈米乳液技術的應用。
According to Stratistics MRC, the Global Nanoemulsion Market is accounted for $12.84 billion in 2024 and is expected to reach $20.17 billion by 2030 growing at a CAGR of 9.2% during the forecast period. A nanoemulsion is a type of emulsified system consisting of finely dispersed droplets of one liquid in another, typically with droplet sizes ranging from 20 to 200 nanometers. These systems are transparent or translucent and are thermodynamically stable. They can carry both hydrophilic and lipophilic compounds, offering a versatile solution for formulating products with improved performance and stability compared to traditional emulsions.
According to a research article by News-Medical.Net, in September 2020, researchers stated that nanoemulsion systems can produce immune responses that are similar to live attenuated vaccines but do not run the risk of reversion.
Increasing demand for skincare and anti-aging products
Nanoemulsions provide enhanced penetration and absorption of active ingredients like vitamins, antioxidants, and peptides, which are key components in skincare formulations. Their ability to deliver these ingredients deeper into the skin improves product efficacy and provides better results for anti-aging benefits. Additionally, nanoemulsions offer improved stability, extended shelf life, and the ability to create lightweight, non-greasy formulations, all of which appeal to consumers seeking more effective, innovative skincare solutions. This demand boosts the adoption of nanoemulsion technology in the cosmetics industry.
Stability issues
Stability issues in nanoemulsions arise due to factors like particle aggregation, phase separation, and coalescence, which can occur over time or under specific storage conditions. These issues are often caused by improper formulation, high energy requirements, or external factors like temperature fluctuations and pH changes. Such instability hampers the market growth by limiting the shelf life and effectiveness of nanoemulsion-based products, particularly in pharmaceuticals and cosmetics.
Growing demand in pharmaceuticals
Nanoemulsions enhance the bioavailability, stability, and solubility of poorly water-soluble drugs, making them ideal for delivering active pharmaceutical ingredients effectively. With increasing research into novel formulations, particularly in targeted therapies, vaccines, and biologics, nanoemulsions offer a promising solution for improved drug absorption and controlled release. The rise in chronic diseases, personalized medicine, and the need for safer, more efficient drug delivery systems further boosts the adoption of nanoemulsion technology in the pharmaceutical sector, fueling market growth.
High production costs
Nanoemulsion requires high production costs due to the need for specialized equipment, advanced raw materials, and complex manufacturing processes to achieve precise control over droplet size and stability. Techniques such as high-pressure homogenization and microfluidization contribute to increased costs. Additionally, ensuring consistency, scalability, and regulatory compliance adds financial burdens. These elevated costs can hamper market growth by limiting accessibility, especially for small and medium-sized enterprises.
Covid-19 Impact
The covid-19 pandemic had a mixed impact on the nanoemulsion market. On the positive side, there was increased demand for nanoemulsions in pharmaceuticals for vaccine delivery systems, antivirals, and personal protective products. The surge in demand for sanitizers, disinfectants, and skin-care products also boosted the market. However, disruptions in supply chains, manufacturing delays, and a slowdown in R&D activities during lockdowns hindered growth. Despite these challenges, the market showed resilience due to the growing need for advanced drug delivery systems.
The oil-in-water nanoemulsion segment is expected to be the largest during the forecast period
The oil-in-water nanoemulsion segment is predicted to secure the largest market share throughout the forecast period. Oil-in-water nanoemulsions are emulsions where tiny droplets of oil are dispersed in a water phase, typically with droplet sizes ranging from 20 to 200 nanometers. This type of nanoemulsion is widely used in pharmaceuticals, cosmetics, and food products. Oil-in-water nanoemulsions offer improved stability, reduced toxicity, and controlled release of active ingredients, making them ideal for drug delivery systems, skincare products, and functional food formulations.
The food & beverages segment is expected to have the highest CAGR during the forecast period
The food & beverages segment is anticipated to witness the highest CAGR during the forecast period. In the Food & Beverages industry, nanoemulsions are used to improve the delivery of flavours, nutrients, and bioactive compounds. They enhance the stability, solubility, and absorption of ingredients like vitamins, antioxidants, and essential oils, making them more effective in products like fortified drinks, functional foods, and flavouring agents. Their ability to deliver consistent quality and maintain emulsions without separation drives innovation in the sector.
Asia Pacific is expected to register the largest market share during the forecast period due to the increasing demand for advanced drug delivery systems, personal care products, and food & beverage applications. Countries like China, India, and Japan are major contributors, driven by expanding pharmaceutical, cosmetic, and nutraceutical industries. The region's rising healthcare awareness, along with growing investments in biotechnology and nanotechnology, supports market expansion. Additionally, the demand for eco-friendly, sustainable products in cosmetics and food sectors is fueling the adoption of nanoemulsions in the region.
North America is expected to witness the highest CAGR over the forecast period driven by advancements in drug delivery systems, pharmaceuticals, and the cosmetic industry. The U.S. is a key market player, with rising demand for innovative drug formulations, including vaccines and biologics. The region benefits from robust R&D activities, technological advancements, and a well-established healthcare infrastructure. Additionally, increasing consumer demand for eco-friendly and sustainable formulations in both cosmetics and food sectors is further boosting the adoption of nanoemulsion technologies in North America.
Key players in the market
Some of the key players profiled in the Nanoemulsion Market include AbbVie Inc., AstraZeneca, Allergan, Sanofi, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Amgen Inc., Merck & Co., Inc., Bayer AG, Eli Lilly and Company, Hoffmann-La Roche Limited, Takeda Pharmaceutical Company Limited, OrganiGram Holdings Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Lupin Pharmaceuticals, Inc., Cipla Limited, Sun Pharmaceutical Industries Limited and Boehringer Ingelheim.
In November 2024, Organigram has introduced FAST(TM) Nanoemulsion Gummies, an innovative addition to their product line-up. These gummies leverage advanced nanoemulsion technology to offer rapid onset of effects compared to traditional cannabis edibles. Each gummy contains an accurately measured dose of cannabinoids, catering to both new and experienced users looking for predictable results.
In July 2024, Lupin Limited has partnered with Huons Co. Ltd., a South Korea-based pharmaceutical firm, to introduce Cyclosporine Ophthalmic Nanoemulsion in the Mexican market. This innovative product is designed to treat chronic dry eye syndrome, providing enhanced bioavailability and prolonged therapeutic effects due to its nanoemulsion-based formulation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.